Minerva Neurosciences, Inc.
NERV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001598646
No open-market purchases or sales by Minerva Neurosciences, Inc. insiders were filed in the last 90 days; 61 institutions reported holding it in 13F filings for Q2 2026, worth $234.8M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Minerva Neurosciences, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- +1 vs. Q3 2024
- Shares held
- 2.09M
- −32.1K (−1.5%) vs. Q3 2024
- Total value
- $4.63M
- −$1.02M (−18.1%) vs. Q3 2024
- New holders
- 4
- 3 more added
- Sold out
- 3
- 4 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NERV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 61 | $234.8M |
| Q1 2026 | 47 | $236.1M |
| Q4 2025 | 33 | $107.7M |
| Q3 2025 | 24 | $4.21M |
| Q2 2025 | 21 | $3.34M |
| Q1 2025 | 22 | $3.31M |
| Q4 2024 | 22 | $4.63M |
| Q3 2024 | 21 | $5.65M |
| Q2 2024 | 21 | $6.65M |
| Q1 2024 | 21 | $5.42M |
| Q4 2023 | 20 | $14.9M |
| Q3 2023 | 20 | $16.6M |
| Q2 2023 | 19 | $19.0M |
| Q1 2023 | 17 | $2.69M |
| Q4 2022 | 19 | $2.75M |
| Q3 2022 | 25 | $18.7M |
| Q2 2022 | 23 | $7.51M |
| Q1 2022 | 33 | $16.3M |
| Q4 2021 | 35 | $16.6M |
| Q3 2021 | 46 | $42.9M |
| Q2 2021 | 68 | $63.2M |
| Q1 2021 | 72 | $91.4M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Minerva Neurosciences, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Federated Hermes, Inc. | 1,351,275 | $3.00M | 0.01% | 00.0% | Unchanged |
| Vanguard Group Inc | 252,060 | $559.6K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 128,100 | $284.6K | 0.00% | −29,100−18.5% | Reduced |
| UBS Oconnor LLC | 107,256 | $238.1K | 0.01% | 00.0% | Unchanged |
| BlackRock, Inc. | 72,669 | $161.4K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 56,456 | $125.4K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 36,878 | $81.9K | 0.00% | +13,829+60.0% | Added |
| Citadel Advisors LLC | 25,764 | $57.2K | 0.00% | +8,525+49.5% | Added |
| Acadian Asset Management LLC | 17,416 | $38.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 16,519 | $36.7K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 16,104 | $35.8K | 0.00% | +5,357+49.8% | Added |
| Wells Fargo & Company | 1,938 | $4.30K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,442 | $3.20K | 0.00% | −466−24.4% | Reduced |
| Royal Bank of Canada | 1,545 | $3.00K | 0.00% | +1,545 | New |
| TFC Financial Management | 186 | $414 | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 100 | $222 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 62 | $138 | 0.00% | +62 | New |
| SBI Securities Co., Ltd. | 53 | $118 | 0.00% | +53 | New |
| Bank of America Corp | 45 | $100 | 0.00% | −12−21.1% | Reduced |
| JPMorgan Chase & Co | 17 | $38 | 0.00% | +17 | New |
| UBS Group AG | 12 | $27 | 0.00% | −10,540−99.9% | Reduced |
| Anchor Investment Management, LLC | 12 | $27 | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −20,224−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −1,175−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |